Zoekresultaten - 467 results

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Publication Type: Peer reviewed scientific article Authors: Adriaenssens, Niels; Scholtes, Beatrice; Bruyndonckx, Robin; Verbakel, Jan Y; De Sutter, An; Heytens, Stefan; Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; Goossens, Herman; Buret, ...

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Publication Type: Peer reviewed scientific article Authors: Adriaenssens, Niels; Scholtes, Beatrice; Bruyndonckx, Robin; Van Ngoc, Pauline; Verbakel, Jan Yvan Jos; De Sutter, An; Heytens, Stefan; Van Den Bruel, Ann; Desombere, Isabelle; Van Damme, Pierre; ...

Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort studyObjectivesDesignSettingParticipantsOutcome measuresResultsConclusionsTrial registration number

Publication Type: Peer reviewed scientific article Authors: Mortgat, Laure; Verdonck, Kristien; Veronik Hutse; Isabelle Thomas; Barbezange, Cyril; Heyndrickx, Leo; Fischer, Natalie; Vuylsteke, Bea; Kabouche, Ines; Ariën, Kevin K; Desombere, Isabelle; Duys ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

NHR, are known to have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 ...

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial.

assigned in a 2:1 ratio to receive either camostat mesylate or a placebo. Outcomes included change in nasopharyngeal viral load, time to clinical improvement, the presence of neutralizing antibodies ...

Porcine Reproductive and Respiratory Syndrome virus (PRRSv): A Cross-Sectional Study on ELISA Seronegative, Multivaccinated Sows

(prevalence–origin–consequences) was not yet investigated. In this study, the prevalence of ELISA non-responders was assessed by measuring PRRS v-specific antibodies in 1400 sows, originating from 70 PRRS v-vaccinating sow herds, ...

Risks related to a possible reduction of the waiting period for dogs after rabies antibody titration to 30 days compared with 90 days of the current EU legislative regime.

Vuta, Vlad; Antoniou, Sotiria-Eleni; Aznar, Inma; Papanikolaou, Alexandra; Roberts, Helen Clare Source: EFSA J, Volume 20, Issue 6 (2022) Keywords: Antibody Dogs EU Pets Rabies serology Travel Abstract: ...

Outbreaks of Foot-and-Mouth Disease in Burundi, East Africa, in 2016, Caused by Different Serotypes.

blood were collected in six of the affected provinces spread over the country. The overall seroprevalence of FMD virus (FMDV) in the affected herds, as determined by antibodies against FMDV non-structural ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

(2022) Keywords: antibodies COVID-19 health determinants population-based Seroprevalence Abstract: KEY FINDINGS Between the last period of wave 1 (14/06-11/07) and the first period of wave 2 (27/09-24/10) ...

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme.

Issue 2 (2022) Keywords: Adult Antibodies, Viral Antigens, Viral Belgium Coronavirus Nucleocapsid Proteins COVID-19 COVID-19 Serological Testing Diagnostic Tests, Routine Enzyme-Linked Immunosorbent Assay ...

QR code

QR code for this page URL